NCT06745765 Virtual Reality for Anxiety in Interventional Radiology Procedures
| NCT ID | NCT06745765 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Preoperative Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 236 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 236 participants in total. It began in 2024-11-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if virtual reality works to reduce anxiety in patients undergoing interventional radiology procedures. The main questions it aims to answer are: Does virtual reality lower anxiety in patients undegoing minimally invasive procedures? Can it help the platient's compliance and operators' satisfaction? Researchers will compare virtual reality to usual preoperative care to see if virtual reality is effective. Participants will: Use virtual reality for 20 minutes before the intervention starts. Complete questionnaires before and after the procedure.
Eligibility Criteria
Inclusion Criteria: * Indication to CT-guided biopsy in local anesthesia * Informed consent signature Exclusion Criteria: * Lack of patient consent to trial. * Lack of eligibility to perform CT-guided needle biopsy, or eligibility to perform the procedure but with administration of general anesthesia or sedation. * patients who do not speak Italian or English will be excluded; * patients with visual and/or hearing impairment; * patients on analgesics or anxiolytics; * patients with the following conditions: dementia, psychiatric disorders; headache, dizziness, recent head injury, epilepsy, and other conditions in which the application of VR glasses has been judged to be potentially harmful; and when the topical anesthetic (lidocaine and prilocaine \[eutectic mixture of local anesthetic (EMLA)\]) or tetracaine (Ametop) was not properly applied before surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06745765 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Preoperative Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06745765 currently recruiting?
Yes, NCT06745765 is actively recruiting participants. Contact the research team at giancarlo.facchini@ior.it for enrollment information.
Where is the NCT06745765 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06745765 clinical trial?
NCT06745765 is sponsored by Istituto Ortopedico Rizzoli. The trial plans to enroll 236 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.